美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

SPDR S&P International Industria

34.71

0.0000

成交量：- -

成交额：- -

市值：2,082.60万

市盈率：3.89

高：34.71

开：34.71

低：34.71

收：34.71

52周最高：34.71

52周最低：34.71

股本：60.00万

流通股本：- -

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):8.93

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

益普生公布2025年上半年强劲业绩并上调全年财务指引

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/IPN/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IPN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPN\",,,,,undefined,":{"symbol":"IPN","market":"US","secType":"STK","nameCN":"SPDR S&P International Industria","latestPrice":34.71,"timestamp":1770670800000,"preClose":34.71,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":600000,"eps":8.9298,"marketStatus":"盘前交易","change":0,"latestTime":"02-10 08:39:08 EST","open":34.71,"high":34.71,"low":34.71,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.9298,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":34.71,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPN\",,,,,undefined,":{"symbol":"IPN","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":600000,"dividePrice":0,"high":34.71,"amplitude":0,"preClose":34.71,"low":34.71,"week52Low":34.71,"pbRate":"--","week52High":34.71,"institutionHeld":0,"latestPrice":34.71,"eps":8.9298,"divideRate":0,"volume":0,"delay":0,"ttmEps":8.9298,"open":34.71,"prevYearClose":34.71,"prevWeekClose":34.71,"prevMonthClose":34.71,"prevQuarterClose":34.71,"fiveDayClose":34.71,"twentyDayClose":34.71,"sixtyDayClose":34.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IPN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-06-16","symbol":"IPN","amount":0.357922,"name":"SPDR S&P International Industria","recordDate":"2017-06-28","payableDate":"2017-06-20","currency":"USD","type":"dividend","dateTimestamp":1497585600000},{"market":"US","date":"2017-03-17","symbol":"IPN","amount":0.016732,"name":"SPDR S&P International Industria","recordDate":"2017-03-29","payableDate":"2017-03-21","currency":"USD","type":"dividend","dateTimestamp":1489723200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IPN\",market:\"US\",,,undefined,":[{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-29","value":0.016732,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-28","value":0.357922,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IPN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IPN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2557399040","title":"益普生公布2025年上半年强劲业绩并上调全年财务指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2557399040","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557399040?lang=zh_cn&edition=fundamental","pubTime":"2025-08-05 12:32","pubTimestamp":1754368320,"startTime":"0","endTime":"0","summary":"在此基础上，我很高兴，益普生在销售和利润方面的全年指引做了上调。\" 2025年全年指引 基于上半年强劲的业绩表现，益普生上调了2025年全年财务指引：  以固定汇率计算，总销售额增长超过7.0%。2025年7月23日，欧盟委员会批准益普生将Cabometyx用于治疗既往接受治疗的晚期神经内分泌肿瘤患者。上述所有风险因素均可能影响益普生未来达成财务目标的能力，而这些目标是基于当前可获取信息并假设宏观经济环境相对稳定的前提下设定的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4744400_ZH44400_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["IPN","BK4007","IPSEY"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}